Injury patterns differ with age in male youth football: a four-season prospective study of 1111 time-loss injuries in an elite national academy.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Jul 2021
Historique:
accepted: 03 12 2020
pubmed: 29 12 2020
medline: 27 7 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

To describe age group patterns for injury incidence, severity and burden in elite male youth football. Prospective cohort study capturing data on individual exposure and time-loss injuries from training and matches over four seasons (2016/2017 through 2019/2020) at a national football academy (U13-U18; age range: 11-18 years). Injury incidence was calculated as the number of injuries per 1000 hours, injury severity as the median number of days lost and injury burden as the number of days lost per 1000 hours. We included 301 players (591 player-seasons) and recorded 1111 time-loss injuries. Overall incidence was 12.0 per 1000 hours (95% CI 11.3 to 12.7) and burden was 255 days lost per 1000 hours (252 to 259). The mean incidence for overall injuries was higher in the older age groups (7.8 to 18.6 injuries per 1000 hours), while the greatest burden was observed in the U16 age group (425 days; 415 to 435). In older age groups, incidence and burden were higher for muscle injuries and lower for physis injuries. Incidence of joint sprains and bone stress injuries was greatest for players in the U16, U17 and U18 age groups, with the largest burden observed for U16 players. No clear age group trend was observed for fractures. Injury patterns differed with age; tailoring prevention programmes may be possible.

Identifiants

pubmed: 33361134
pii: bjsports-2020-103430
doi: 10.1136/bjsports-2020-103430
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

794-800

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Eirik Halvorsen Wik (EH)

Aspetar Sports Injury and Illness Prevention Programme (ASPREV), Department of Research and Scientific Support, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar eirik.wik@aspetar.com.
Oslo Sports Trauma Research Center (OSTRC), Department of Sports Medicine, Norwegian School of Sports Sciences, Oslo, Norway.

Lorenzo Lolli (L)

Football Performance and Science Department, Aspire Academy, Doha, Qatar.
Football Exchange, Research Institute of Sport Sciences, Liverpool John Moores University, Liverpool, UK.

Karim Chamari (K)

Aspetar Sports Injury and Illness Prevention Programme (ASPREV), Department of Research and Scientific Support, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar.

Olivier Materne (O)

Aspetar Sports Injury and Illness Prevention Programme (ASPREV), Department of Research and Scientific Support, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar.

Valter Di Salvo (V)

Football Performance and Science Department, Aspire Academy, Doha, Qatar.
Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Warren Gregson (W)

Football Performance and Science Department, Aspire Academy, Doha, Qatar.
Football Exchange, Research Institute of Sport Sciences, Liverpool John Moores University, Liverpool, UK.

Roald Bahr (R)

Aspetar Sports Injury and Illness Prevention Programme (ASPREV), Department of Research and Scientific Support, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar.
Oslo Sports Trauma Research Center (OSTRC), Department of Sports Medicine, Norwegian School of Sports Sciences, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH